Interchangeable Biologics Clarity Act
Official title: A bill to provide for a period of exclusivity for first interchangeable biological products.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
Interchangeable Biologics Clarity Act
This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 4303: Interchangeable Biologics Clarity Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-4303/
"S. 4303: Interchangeable Biologics Clarity Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4303/.
S. 4303, 117th Cong. (2026), https://openamerica.io/bill/117-S-4303/.
[S. 4303: Interchangeable Biologics Clarity Act](https://openamerica.io/bill/117-S-4303/)